Instructions for Welgia (semaglutide) [Ozempic] solution
Description Welgia
The drug Ozempic® is intended for adults from 18 years old and is used as an additional agent for a low-calorie diet and exercise to control body weight. It helps both to reduce weight and to maintain it at the achieved level. Ozempic® is recommended for the following
indications:
Body mass index (BMI) ≥ 30 kg/m² (obesity) or
BMI ≥ 27 kg/m² to < 30 kg/m² (overweight)
The drug is particularly effective in the presence of comorbidities associated with overweight, such as prediabetes, type 2 diabetes mellitus, hypertension, dyslipidemia, obstructive sleep apnea, and cardiovascular disease.
If there is no weight loss or deterioration after taking the drug, contact your doctor to correct the treatment regimen.
Semaglutid: Your helper for overweight and diabetes
Description of the drug Ozempic
Semaglutide is a synthetic analog of the hormone glucagon-like peptide-1 (GLP-1), which is produced in the body after meals. The drug is available as an injection solution in a prefilled syringe pen. Each pen contains 6.8 mg of semaglutide in 3 ml of solution, equivalent to 4 1.7 mg doses.
Mechanism of action Welgia
Semaglutide affects receptors in the brain that regulate appetite. It can help people feel fuller more quickly, keep feeling fuller for longer, and reduce their craving for food. In addition, the drug slows the evacuation of food from the stomach, contributing to a prolonged feeling of fullness.
Benefits
Semaglutide not only reduces appetite, but also improves metabolism. It can reduce waist circumference, normalize lipid and glucose levels in the blood, and improve cardiovascular parameters such as blood pressure and pulse.
Indications for use Ozempic
The drug Ozempic® is recommended as an adjunct to a low-calorie diet and physical activity to correct and control body weight. It is also used to treat type 2 diabetes, helping improve blood glucose control.
Efficiency
Regular use of semaglutide helps not only to reduce weight, but also to reduce the risk of cardiovascular diseases, type 2 diabetes, reproductive disorders, joint and liver diseases.
Features of application Welgia
It is important to note that semaglutide contains sodium, so it should be used with caution in patients with kidney and heart disease. It is also necessary to consult a doctor before starting a course of treatment.
Conclusion
semaglutide is an innovative tool to combat overweight and complications associated with increased body weight. Its complex mechanism of action makes it an effective tool for achieving and maintaining a healthy weight, as well as improving the general condition of the body.
How to use the drug Welgia:
A starting dose is 0.25 mg given once a week.
The maximum maintenance dose of semaglutide is 2.4 mg, also taken once a week. To reduce the risk of gastrointestinal side effects, the dose should be increased for sixteen weeks, starting at 0.25 mg and going up to 2.4 mg once a week.
If serious gastrointestinal symptoms occur, the dose may be delayed or reverted to the previous dose until symptoms resolve. Exceeding 2.4 mg a week is not recommended.